At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Sorted Ascending Name Title Type Shares Traded Price Range
Feb 26, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 1,900 9.99 - 10.28
Feb 26, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 6,100 9.49 - 9.97
Feb 26, 2008 topper james n Director Buy 1,900 9.99 - 10.28
Feb 26, 2008 topper james n Director Buy 6,100 9.49 - 9.97
Feb 27, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 8,600 9.95 - 10.18
Feb 27, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 14,700 9.65 - 9.94
Feb 27, 2008 topper james n Director Buy 8,600 9.95 - 10.18
Feb 27, 2008 topper james n Director Buy 14,700 9.65 - 9.94
Feb 28, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 5,762 9.97 - 10.49
Feb 28, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 2,038 9.84 - 9.96
Feb 28, 2008 licholai gregory p Officer Sell 10,000 10.00 - 10.10
Feb 28, 2008 palling david Officer Sell 2,500 10.46 - 10.55
Feb 28, 2008 topper james n Director Buy 5,762 9.97 - 10.49
Feb 28, 2008 topper james n Director Buy 2,038 9.84 - 9.96
Feb 29, 2008 crowley john f Officer Option Execute 10,000 0.64
Feb 29, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 8,637 9.63 - 10.50
Feb 29, 2008 topper james n Director Buy 8,637 9.63 - 10.50
Mar 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 9.85
Mar 3, 2008 crowley john f Officer Automatic Sell 4,497 10.00
Mar 3, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 18,426 9.83 - 10.00
Showing 141-160 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy